These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22740973)

  • 41. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
    Yugawa T; Kiyono T
    Rev Med Virol; 2009 Mar; 19(2):97-113. PubMed ID: 19156753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
    Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
    Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
    Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
    Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Piwil2 is reactivated by HPV oncoproteins and initiates cell reprogramming via epigenetic regulation during cervical cancer tumorigenesis.
    Feng D; Yan K; Zhou Y; Liang H; Liang J; Zhao W; Dong Z; Ling B
    Oncotarget; 2016 Oct; 7(40):64575-64588. PubMed ID: 27602489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glycogene expression profiles based on microarray data from cervical carcinoma HeLa cells with partially silenced E6 and E7 HPV oncogenes.
    Aco-Tlachi M; Carreño-López R; Martínez-Morales PL; Maycotte P; Aguilar-Lemarroy A; Jave-Suárez LF; Santos-López G; Reyes-Leyva J; Vallejo-Ruiz V
    Infect Agent Cancer; 2018; 13():25. PubMed ID: 30038662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. E6 and E7 from human papillomavirus type 16 cooperate to target the PDZ protein Na/H exchange regulatory factor 1.
    Accardi R; Rubino R; Scalise M; Gheit T; Shahzad N; Thomas M; Banks L; Indiveri C; Sylla BS; Cardone RA; Reshkin SJ; Tommasino M
    J Virol; 2011 Aug; 85(16):8208-16. PubMed ID: 21680517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
    Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B
    Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis.
    Yim EK; Park JS
    Cancer Res Treat; 2005 Dec; 37(6):319-24. PubMed ID: 19956366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Interaction between folate and the expression of human papillomavirus 16 E6/E7 mRNA in the progression of cervix carcinogenesis].
    Nan J; Ding L; Liu XZ; Li J; Wu TT; Chen X; Wang JT
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jun; 37(6):852-7. PubMed ID: 27346115
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells.
    Lee SJ; Cho YS; Cho MC; Shim JH; Lee KA; Ko KK; Choe YK; Park SN; Hoshino T; Kim S; Dinarello CA; Yoon DY
    J Immunol; 2001 Jul; 167(1):497-504. PubMed ID: 11418688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HPV16 E6E7 up-regulates KIF2A expression by activating JNK/c-Jun signal, is beneficial to migration and invasion of cervical cancer cells.
    Wang Y; Wang J; Zhao A; Huang X; Zhang X
    Open Med (Wars); 2022; 17(1):1780-1787. PubMed ID: 36447525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells.
    Rampias T; Boutati E; Pectasides E; Sasaki C; Kountourakis P; Weinberger P; Psyrri A
    Mol Cancer Res; 2010 Mar; 8(3):433-43. PubMed ID: 20215420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vaccination of full-length HPV16 E6 or E7 protein inhibits the growth of HPV16 associated tumors.
    Li YL; Qiu XH; Shen C; Liu JN; Zhang J
    Oncol Rep; 2010 Nov; 24(5):1323-9. PubMed ID: 20878127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of HPV16 E6 or E7 increases integration of foreign DNA.
    Kessis TD; Connolly DC; Hedrick L; Cho KR
    Oncogene; 1996 Jul; 13(2):427-31. PubMed ID: 8710383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7.
    Sdek P; Zhang ZY; Cao J; Pan HY; Chen WT; Zheng JW
    Int J Oral Maxillofac Surg; 2006 Jul; 35(7):653-7. PubMed ID: 16513324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis.
    Yuan H; Fu F; Zhuo J; Wang W; Nishitani J; An DS; Chen IS; Liu X
    Oncogene; 2005 Jul; 24(32):5069-78. PubMed ID: 15856013
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eradication of cervical cancer in vivo by an AAV vector that encodes shRNA targeting human papillomavirus type 16 E6/E7.
    Sato N; Saga Y; Uchibori R; Tsukahara T; Urabe M; Kume A; Fujiwara H; Suzuki M; Ozawa K; Mizukami H
    Int J Oncol; 2018 Mar; 52(3):687-696. PubMed ID: 29344635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Post-treatment human papillomavirus antibody kinetics in cervical cancer patients.
    Piontek T; Harmel C; Pawlita M; Carow K; Schröter J; Runnebaum IB; Dürst M; Graw F; Waterboer T
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1773):20180295. PubMed ID: 30955486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
    Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322
    [TBL] [Abstract][Full Text] [Related]  

  • 60. E6 and E7 oncoproteins from human papillomavirus type 16 induce activation of human transforming growth factor beta1 promoter throughout Sp1 recognition sequence.
    Peralta-Zaragoza O; Bermúdez-Morales V; Gutiérrez-Xicotencatl L; Alcocer-González J; Recillas-Targa F; Madrid-Marina V
    Viral Immunol; 2006; 19(3):468-80. PubMed ID: 16987065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.